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ParasitesSUMOylation, a posttranslational modiﬁcation of proteins, has been recently described as vital in eukaryotic cells.
In a previous work, we analyzed the role of SUMO protein and the genes encoding the putative enzymes of the
SUMOylation pathway in the parasite Giardia lamblia. Although we observed several SUMOylated proteins,
only the enzyme Arginine Deiminase (ADI) was conﬁrmed as a SUMOylated substrate. ADI is involved in the
survival of the parasite and, besides its role in ATP production, it also catalyzes the modiﬁcation of arginine
residues to citrulline in the cytoplasmic tail of surface proteins. During encystation, however, ADI translocates
to the nuclei and downregulates the expression of the Cyst Wall Protein 2 (CWP2). In this work, we made site-
speciﬁc mutation of the ADI SUMOylation site (Lys101) and observed that transgenic trophozoites did not
translocate to the nuclei at theﬁrst steps of encystation but shuttled in the nuclei late during this process through
classic nuclear localization signals. Inside the nuclei, ADI acts as a peptidyl arginine deiminase, being probably
involved in the downregulation of CWPs expression and cyst wall formation. Our results strongly indicate that
ADI plays a regulatory role during encystation in which posttranslational modiﬁcations of proteins are key
players.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
An interesting feature of parasites is their ability to rapidly and
efﬁciently adapt to changes of the environment in order to survive. A
dynamic survival mechanism is used by Giardia lamblia (syn. Giardia
duodenalis, Giardia intestinalis), a parasitic protozoan early divergent in
evolutionary history and a major cause of waterborne diarrheal disease
[1,2]. The life cycle of Giardia is simple, but sufﬁcient to adapt to the
microenvironment, with two clearly different stages adapted to survive
outside (cysts) or inside (trophozoites) the host.
Cysts are covered by a wall composed of proteins (CWPs: Cyst Wall
Proteins) and a glycopolymer in insoluble ﬁbrils [3]. This extracellular
wall permits the parasite to survive in the environment, where it may
persist in fresh water and also resist disinfectants. Transmission of
Giardia is via the fecal–oral route, either indirectly through contaminated
water or food, or directly from person to person [2]. After ingestion and
exposure to the acidic environment of the host's stomach, cysts rapidlyn Médica Mercedes y Martín
4 351 4681465; fax: +54 351
).differentiate into vegetative trophozoites via the excyzoite stage. The
excyzoite divides twice giving rise to trophozoites, which attach to the
intestinal epithelium with an adhesive disk in order to proliferate and
to avoid being swept away with the intestinal content. To evade the
host's immune response, it changes its surface proteins (VSPs: Variant-
speciﬁc Surface Proteins) in a process called antigenic variation. In the
lower part of the small intestine, and in response to host signals, the
trophozoites encyst. Synthesis of CWPs begins early in encystation and
leads to the formation of novel large encystation secretory vesicles
(ESVs), which export CWPs to the nascent cyst wall. The late phase of
encystations consists in the secretion of cyst wall material to the parasite
surface, followed by the assembly of the ﬁlamentous portion of the cyst
wall.
In parasites, efﬁciency to react to changes in the microenvironment
is directly related to their survival odds. Posttranslational protein
modiﬁcations enable cells to rapidly and speciﬁcally respond to endo-
genous or exogenous stimuli, avoiding time- and energy-consuming
de novo protein synthesis. In eukaryotic cells, modiﬁcations of arginine
residues by deimination (protein citrullination) are catalyzed by
peptidyl arginine deiminases (PADs), generating irreversible structural
modiﬁcations of protein by the conversion of arginine residues to
citrulline residues. Because no citrulline tRNA exists, the presence of
citrulline residues in proteins has to be the result of posttranslational
modiﬁcations (reviewed in [4]).
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Deiminase (ADI), besides its role as a metabolic enzyme converting
free L-arginine into L-citrulline, is able to act as a PAD. During the prolif-
erative stages of growth, ADI was observed to deiminate and convert
the arginine of the conserved cytoplasmic tail of VSPs to citrulline, a
modiﬁcation that is important in the regulation of antigenic variation
[5]. The change of one VSP into another allows the parasite to evade
the humoral immune response and to prolong infections within the
host. There is another way by which Giardia trophozoites are involved
in the inhibition of the immune response applied by the host. It has
been demonstrated that ADI, enolase, and ornithine carbamoyl transfer-
ase (OCT) enzymes are released into themediumwhen the trophozoite
is in contact with intestinal epithelial cells in vitro [6]. The presence of
ADI and OCT in the gut lumenmay contribute to L-Arg depletion, and ﬁ-
nally impact the availability of free L-Arg to be used for the production of
nitric oxide by intestinal epithelial cells (reviewed in [7]). Also, a growth
arrest of intestinal epithelial cells, changes in the surface markers and
cytokine response of in vitro-activated human monocyte-derived den-
dritic cells and impaired T cell proliferation are affected due to reduced
arginine availability [8–10]. All this, and the fact that ADI is an essential
enzyme for Giardia survival indicate that ADI is a potential target for the
development of therapeutic agents for the treatment of giardiasis [11].
ADI translocates to the nuclei late during the encystation process,
suggesting a role during the differentiation of cysts. Translocation of
ADI to nuclei takes place early in ADI-transgenic cells, in which the
high overexpression of ADI together with its nuclear translocation
avoids CWP2 expression [5]. Therefore, probably ADI causes genes in
the CWP family to turn off, as an essential requirement to successfully
complete the encystation stage.
Numerous studies have shown that, in eukaryotic cells, nuclear pro-
teins or proteins that crisscross the nuclearmembrane contain a stretch
of basic amino acid sequence known as the Nuclear Localization Signal
(NLS). Proteins with a NLS are transported across the nuclear envelope
by a family of transport proteins called importins. In addition,
nucleocytoplasmic transport is modulated by posttranslational modiﬁ-
cation of the cargo protein, including phosphorylation, acetylation and
SUMOylation, which could mask or expose the NLS of the protein.
SUMOylation is characterized by the covalent attachment of SUMO
(Small Ubiquitin-related MOdiﬁer) proteins to speciﬁc lysine residues
in target proteins [12,13]. The molecular weight of SUMO is approxi-
mately 11 kDa, which usually generates a rise in the molecular weight
of the target protein. We previously demonstrated that the transloca-
tion of ADI from the cytoplasm to the nuclei and the increased Mr ob-
served in nuclear fractions of encysting cells may be explained by
SUMOylation of the enzyme [5]. Moreover, recently, we disclosed the
presence of a single gene in Giardia (gsumo) that encodes the SUMO
protein, and identiﬁed genes encoding putative enzymes of the
SUMOylation pathway [14].
The present study focuses on the role of ADI during encystation of
Giardia, and describes the function of the enzyme inside the nuclei.
Furthermore, we analyze how SUMOylation of the enzyme inﬂuences
its translocation to the nuclei and consequently its participation in the
modulation of cyst differentiation in Giardia.
2. Materials and methods
2.1. Biochemical reagents
Unless otherwise stated, all chemicals were purchased from Sigma
(St. Louis, MO).
2.2. Parasites
Trophozoites of the isolate WB, clone 1267 (WB/1267) (American
Type Culture Collection catalog number 50582) were cultured in TYI-
S-33 supplemented with 10% fetal bovine serum and bovine bile for48 h at 37 °C [15]. Cultures were harvested by chilling on ice followed
by agitation to dislodge attached cells. Trophozoites were collected by
centrifugation at 500 g for 10 min at 4 °C and washed three times
with PBS. Trophozoites of the WB/1267 clone were transfected by
electroporation and selected with puromycin [16,17]. A two-step
encystation procedure was used by increasing the medium pH and by
addition of porcine bile as reported by Boucher and Gillin [18].
2.3. Expression of ADI, ADI variants and SUMO in WB/1267 trophozoites
To predict the SUMOylation sites, SUMOsp 2.0 [19] and the PCI-
SUMO (from the Department of Systems and Computer Engineering
from Carleton University) programs were used. The Quik Change
Mutagenesis Kit (Stratagene) was used to introduce point mutations
in the SUMOylation site of the adi gene. The sequences of the primers
were: ADIK101A-HAF: 5′-gcaatggcctcgctggcgtacgagctccatgc-3′ and
ADIK101A-HAR: 5′-gcatggagctcgtacgccagcgaggccattgc. Point mutations
in the sites of the nuclear localization signals were introduced using
the following primers: mNLS1F: 5′-gaccagcagataaccaccgcggcgggaa
tagtcatgggccag-3′ and mNLS1R: 5′-ctggcccatgactattcccgccgcggtggttat
ctgctggtc-3′; mNLS2F: 5′-accacccggcgcggaatagcggcgggccagtttcaggc-3′
and mNLS2R: 5′-gcctgaaactggcccgccgctattccgcgccgggtggt-3′; mNLS3F:
5′-cagtttcaggcggcgcagaggaggc-3′ and mNLS3R: 5′-gcctcctctgcgccgcctg
aaactg-3′. The entire open reading frame of each mutant gene was
sequenced to ensure that the appropriate mutation was obtained with-
out incorporation of undesiredmutations (Macrogen). To constitutively
express ADI (ADI-HA cells), mNLS and ADIK101A (ADIK101A-HA cells),
the plasmid pTubHApac with HA at the C-terminus was employed
[20] SUMO-HA transfected cells were expressed as previously described
[14]. The vectors contain a puromycin cassette under the control of the
endogenous non-regulated tubulin promoter for cell selection. Stable
trophozoite transfection was performed as previously described [16,
17,21–23]. Drug resistant trophozoites were usually apparent by 7–10
days post transfection.
2.4. Immunoﬂuorescence
Cells were washed with PBSm (1% growth medium in PBS, pH 7.4),
allowed to attach to multiwell slides in a humidiﬁed chamber at 37 °C
for 1 h, and the wells were ﬁxed with fresh 4% formaldehyde for
40 min. The cells were incubated sequentially with blocking solution
(10% goat serum and 0.1% Triton X-100 in PBS) at 37 °C for 30 min
and incubated with the speciﬁc mAb (1:300) in PBS containing 3%
normal goat serum and 0.1% Triton X-100 for 1 h at 37 °C, followed by
incubation with FITC-conjugated goat anti-mouse (1:200) secondary
antibody (Cappel Laboratories) at 37 °C for 1 h. For double staining,
FITC or Texas red conjugated anti-HA mAb (1:100) (Sigma, St. Louis,
MO) to detect HA-tagged proteins, and polyclonal Ab against ADI
(1:800) (kindly provided by A. Hehl) or anti-SUMO (13C5) monoclonal
Ab (1:100) (mAb) [14], followed by incubation with FITC or Texas Red-
conjugated goat anti-mouse antibody (1:200) (Cappel Laboratories),
were used. FITC-conjugated anti-CWP1 mouse mAb (1/200) (Water-
borne, New Orleans, LA, USA) was also used. Control with non-related
antibodies was included. Finally, preparations were washed and
mounted in Vectashield mounting media. Images were collected on
Olympus FV1000 confocal microscope using 63× oil-immersion objec-
tives (NA 1.32, zoomX). Fluorochromes were excited using an argon
laser at 488 nm for FITC and a krypton laser at 568 nm for Texas Red.
Detector slits were conﬁgured to minimize any crosstalk between the
channels. Differential Interference Contrast (DIC) imageswere collected
simultaneously with the ﬂuorescence images by use of a transmitted-
light detector. Images were processed using ImageJ and Adobe
Photoshop 8.0 (Adobe Systems) software. For quantitative studies, all
images of a given experiment were exposed and processed identically.
At least 70–100 cells expressing each type of protein were examined.
The data were statistically evaluated using Student's t test.
Fig. 1. ADI is a SUMOylated enzyme. A) Direct IFA and confocal microscopy on permeabilized cells at different points after induction of the encystation process shows a cytoplasmic and
nuclear distribution of ADI-HA (green) by using FITC-labeled anti-HA mAb. ADI-HA partially colocalizes (yellow merge) with SUMO (red) detected by using an anti-SUMOmAb (13C5).
Nuclear DNAwas labeledwith DAPI (blue). The scatter plots of the two labels show the colocalization.Mander's overlap coefﬁcient (M). Bars, 3 μm. B) SUMO-HA transgenic cellswere used
to analyze the localization of ADI. Anti-HAmAbwas used to detect SUMO-HA in transgenic cells (green). ADI was detected using a speciﬁc polyclonal antibody (red). Partial colocalization
(yellowmerge)with ADIwas observed. Nuclear DNAwas labeledwith DAPI (blue). The scatter plots of the two labels show the colocalization.Mander's overlap coefﬁcient (M). Bars, 3 μm.
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Fig. 2. SUMOylation site in ADI. A) 3D model of ADI built with the web server Phyre2 to predict ADI protein structure. Residues of the SUMOylation motif are in yellow. This ﬁgure was
prepared using the PyMOL program (DeLano Scientiﬁc, USA). Secondary structure of ADI is also represented showing that the Lys101 (K101) is located in a loop ﬂanked by two helixes
with Lys101 (K101) clearly exposed. B) IFA and confocal microscopy on permeabilized ADIK101A-HA transgenic cells labeled with FITC-conjugated anti-HA mAb (green). Native and
transgenic ADI is labeledwith Texas Red-conjugated anti-ADI pAb (red). There is a strong colocalization in cytoplasm (yellowmerge) both in growing and encysting trophozoites. Flagellar
staining is observed in growing trophozoites (arrow). The scatter plots correspond to the colocalization analysis. Mander's overlap coefﬁcient (M). DIC (differential interference contrast)
microscopy is shown. Bars, 3 μm. C) Western blotting performed during encystation (36 h) using anti-HA mAb in ADI-HA and ADIK101A-HA transgenic cells shows multiple bands. An in-
crease inmolecularmass from a 64–66 kDa to an 85 kDaband is shown (black arrow). Absence of 85 kDa band corresponding to the SUMOylatedADI form is observed inADIK101A-HA cells.
Line 1: Mr: Relative Molecular Mass (kDa). D)Western blotting using HRP-conjugated anti-HAmAbwas performed to detect ADI bands after immunoprecipitation with anti-SUMOmAb
(13C5) inADI-HA (a, b, and c) andADIK101A-HA transgenic cells (d, e, and f) 36 h after the induction of the encystation process. (a andd)Control using a non-related antibody; (b and e) anti-
SUMOmAb; (c and f) ADI in lysate before IPP. E) Dot-blotting to detect citrullination of theHis6-CRGKA peptide after incubationwith puriﬁed enzymes ADI-HA and ADIK101A-HA. A non-
related puriﬁed enzyme ESCP-HA was used as a negative control. Dot blotting to detect His6-CRGKA was performed using anti-H6 mAb.
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Confocal immunoﬂuorescence microscopy and quantitative
colocalization analysis were performed using Fiji image processing
package (http://ﬁji.sc/wiki/index.php/Fiji). Background was corrected
using the threshold value for all channels to remove background and
noise levels completely. The Mander's (M) overlap coefﬁcient was
examined. TheM values range from 0 to 1.0. If the image has an overlap
coefﬁcient of 0.5, it implies that 50% of both its objects, i.e. pixels,
overlap. A value of zero means that there are no overlapping pixels.
This coefﬁcient is not sensitive to the limitations of typical ﬂuorescence
imaging [24–27]. Colocalization is considered in the range from 0.7 to
1.0.2.6. Flow cytometry analysis
For the evaluation of the completion of the encystation process,
trophozoites were grown to a monolayer in pre-encysting media and
induced to encyst as described below. After 36 h, encysting cells and
cysts were harvested by chilling on ice followed by centrifugation at
500 g for 10 min at 4 °C. To analyze stain cell surface expression of
CWPs (cysts), cellswerewashedwith PBS and stainedwith FITC-labeled
anti-CWP1 (1:100 in PBS) for 1 h at 4 °C. Afterwashing three timeswith
PBS, cells were ﬁxed in 4% paraformaldehyde. Controls included the use
of an unrelated antibody. Cells were analyzed on a Cytoron Absolute
Cytometer (Ortho Diagnostic System). Data were analyzed using FlowJo
Analysis Software.
Fig. 3. Entry of ADI to nuclei is enhanced by SUMOylation of the enzyme. A) IFA and confocalmicroscopy shows the localization of ADI in the cytoplasm and nuclei inADI-HA encysting cells
(36 h) butmainly in the cytoplasm ofmutated trophozoites (ADIK101A-HA). Right panels show the differential interference contrast (DIC) images. Scale bar, 10 μm. B)Quantiﬁcation of cells
presenting nuclear transgenic ADI (presented as a percentage of total counted transfected cells) at 24 or 36 h after induction of the encystation process showed a signiﬁcant reduction in
nuclear localization inADIK101A-HA comparedwith ADI-HA transgenic cells. Data represents themeans± s.d. of three independent experiments, *p b 0.05. C) Confocalmicroscopy of IFA in
encysting ADIK101A-HA trophozoites shows no colocalization between ADIK101A-HA and the giardial SUMO at different times during the encystation process. ADIK101A-HA was labeled
with FITC-conjugated anti-HA mAb (green) while gSUMOwas labeled with Texas Red-conjugated anti-SUMO (13C5) mAb (red). Nuclei were stained with DAPI (blue). Scale bar, 10 μm.
The scatter plots (lower panels) correspond to the colocalization analysis. Mander's overlap coefﬁcient (M). D) Kinetics of the encystation process (0, 8, 16, 24, 32, 40, 48, and 56 h) to
analyze the localization of ADIK101A-HA transgenic cells. ADIK101A-HA was labeled with Texas Red-conjugated anti-HA mAb (red); CWP1 was labeled with FITC-conjugated anti-CWP1
mAb (green). Nuclei were stained with DAPI (blue). Localization of ADIK101A-HA in nuclei is indicated (arrow). Scale bar, 3 μm. In the lower part, a diagram of the process is drawn
showing the increase of CWP (green) and the kinetics of the localization of the enzyme in the nuclei (violet).
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Total protein (20 μg) from parasite lysates were harvested and incu-
bated with sample buffer and protease inhibitors, boiled for 10 min andseparated on 12% Bistris gels. Sampleswere transferred to nitrocellulose
membranes, blockedwith 5% skimmedmilk and 0.05% Tween 20 in TBS,
and incubated with anti-HA mAb (1/1000) diluted in the same buffer.
After incubation with horseradish peroxidase-conjugated polyclonal
Table 1
In silico prediction of nuclear localization. The different mNLS mutants used in the present study are shown. The mutated residues are indicated in gray.
Sequence NLSs
RRGIVMGQFQAPQRRRE PQRRREQ
NLS RRGIVMGQFQAPQRRREQ Bound Bound
mNLS1 AAGIVMGQFQAPQRRREQ Not bound Bound
mNLS2 RRGIAAGQFQAPQRRREQ Bound Bound
mNLS3 RRGIVMGQFQAAQRRREQ Bound Not bound
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were visualized with autoradiography. Controls included the use of an
unrelated antibody.
2.8. Immunoprecipitation assays
Giardia trophozoites were harvested and disrupted in lysis buffer
(50 mM Tris, pH 8.0, 120 mM NaCl, 5 mM EDTA, 1% Triton X-100, and
protease inhibitors) for 30 min on ice and centrifuged at 13,000 g for
5 min at 4 °C. The cell lysate was precleared by using protein A/G-
Sepharose beads (Santa Cruz Biotechnology, Santa Cruz, CA) for
30 min at 4 °C, and subsequently subjected to immunoprecipitation
by using 300 μl of anti-SUMO mAb (13C5). After incubation overnight
at 4 °C, protein L-agarosewas added, and the incubation was continued
for 4 h. Beads were pelleted at 700 g and washed four times with wash
buffer (50 mM NaH2PO4, 300 mM NaCl pH 8.0, 0.1% Triton X-100, and
protease inhibitors). Beads were suspended in sample buffer and boiled
for 10 min before Western blot analysis.
2.9. Citrullination assay
For IFA of ﬁxed cells, trophozoites were cultured in encysting medi-
um and were harvested after 36 h of encystation. Citrullinated proteins
were detected by using the anti-citrulline (modiﬁed) detection kit
(Upstate) as previously described [28]. Controls included omission of
the anti-citrulline antibody or absence of the chemically modifying
citrulline step. Preparations were mounted in Vectashield mounting
media. Images were collected on an Olympus FV1000 confocal micro-
scope using 63× oil-immersion objectives (NA 1.32, zoomX). Differen-
tial interference contrast (DIC) images were collected simultaneously
with the ﬂuorescence images by use of a transmitted-light detector. Im-
ages were processed using ImageJ and Adobe Photoshop 8.0 (Adobe
Systems) software.
2.10. ADI activity
ADI activity was assayed by measuring the modiﬁcation of His6-
CRGKA peptide to His6-CcitGKA as we previously described [5]. Brieﬂy,
trophozoites expressing ADI-HA, ADIK101A-HA, mNLS1, mNLS2,Fig. 4.Nuclear translocation of ADI depends on nuclear localization signals.A)Western blotting u
bands. Presence of the 85 kDa band corresponding to the SUMOylated ADI form is observed in
performed by incubation of the His6-CRGKA peptide with puriﬁed enzymes from the mutant
and a non-related puriﬁed enzyme ESCP-HA was used as a negative control. Dot blotting to d
His6-CRGKA (or His6-CCitGKA) was detected using anti-His mAb. C) Fluorescence analysis of pa
ADI-HA proteins were labeled with Texas Red-conjugated anti-HAmAb; CWP1 was labeled wit
images and insets of DAPI staining of the nuclei are shown. Scale bar, 10 μm. D) Quantiﬁcatio
transfected cells) at 36 h after induction of the encystation process inmNLS transgenic trophozo
the number of nuclear transgenic ADI between mNLSmutant transgenic cells and ADI-HA tropmNLS3 and ESCP-HA [22] were cultured, collected and sonicated in
PBS buffer at 4 °C until there were no intact cells and centrifuged at
700 g for 10 min. All HA-tagged proteins from transfected trophozoites
were puriﬁed using anti-HA and protein A/G-agarose as previously de-
scribed [22]. 5mMof soluble His6-CRGKApeptide (10 mg/ml of peptide
in ADI activity buffer: 50 mM Tris-HCl pH 7.6, 2 mM DTT and 5 mM
CaCl2) was mixed with puriﬁed HA-tagged proteins for 16 h at 50 °C.
After samples were boiled for 5 min, the peptide was puriﬁed by using
Ni-agarose beads and was subjected to Dot blot and citrullination as-
says. Anti-histidine mAb (1/200) (Invitrogen Life Technologies) was
used to detect Histidine in Dot blot assays.2.11. Real time PCR
Cultured wild-type and transgenic trophozoites were homogenized
in Trizol reagent (Invitrogen Life Technologies) and stored at−80 °C
before total RNA extractions, according to the manufacturer's protocol.
RNAwas treatedwithDNase (Promega) before determination of nucleic
acid concentration and cDNA synthesis with RevertAid™ Reverse Tran-
scriptase (Fermentas). cDNAwas analyzed for wild-type and transgenic
trophozoite genes using real-time PCR SYBR Green Master Mix from
Invitrogen (Invitrogen Life Technologies, Carlsbad, USA) single stranded
cDNA (100 ng of the input total RNA equivalent), and 800 nM of ampli-
ﬁcation primer were used in a reaction volume of 20 μl. Speciﬁc primers
were designed for detection of the cwp1, cwp2, cwp3 and gdh genes:
cwp1realF (AACGCTCTCACAGGCTCCAT) and cwp1realR (AGGTGGAGCT
CCTTGAGAAATTG); cwp2realF (TAGGCTGCTTCCCACTTTTGAG) and
cwp2realR (CGGGCCCGCAAGGT); cwp3realF (GCAAATTGGATGCCAAAC
AA) and cwp3realR (GACTCCGATCCAGTCGCAGTA). Runs were per-
formed on a 7500 standard system (Applied Biosystems, USA). The
relative-quantitative RT-PCR conditions were: 50 ºC for 2 min, 95 ºC
for 10 min and 40 cycles at 95 ºC for 15 s and 60 ºC for 1 min. Gene ex-
pression was normalized to the housekeeping gene gdh (f: 5′AGGGCG
GCTCCGACTTT 3′ and r: 5′ AGCGCATGACCTCGTTGTC 3′ primers) and
calculated using theΔΔCtmethod.Melt curve analyses were performed
to ensure the speciﬁcity of theqPCRproduct. Statistical analysiswas car-
ried out using GraphPad Prism software (GraphPad Software, Inc.). The
t-test was used to determine differences between wild-type cells (con-
trol group) and transgenic cells.sing anti-HAmAb inmutant forms of ADI (mNLS1–mNLS3) transgenic cells showsmultiple
all mutant forms. Line 1: Mr: Relative Molecular Mass (kDa). B) Citrullination assay was
forms of mNLSs transfected cells. ADI-HA puriﬁed enzyme was used as positive control
etect His6-CCitGKA was performed using anti-citrulline (modiﬁed) antibody. The peptide
rasites transfected with mutant forms of ADI (mNLS1–mNLS3) during encystation. Mutant
h FITC-conjugated anti-CWP1mAb. DIC: differential interference contrast images. Merged
n of cells presenting nuclear transgenic ADI (presented as a percentage of total counted
ites. Data represents themeans± s.d. of three independent experiments. E) Ratio between
hozoites. Gray bars indicate the relative reduction compared with ADI-HA.
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As crystal structure for the ADI enzyme in Giardia is not available in
Protein Data Bank, we used the web server Phyre2 [29] to predict ADIprotein structure. We established the putative three dimensional local-
ization of the SUMOylationmotif (LKYE), deﬁning the orientation of the
Lys101 (or K101) residue. Three-dimensional structures were prepared
using PyMol (DeLano Scientiﬁc, USA).
Fig. 5. Citrullination of histones during encystation. A) IFA and confocal microscopy using
an anti-citrulline pAb in growingwild-type trophozoites (T), encysting cells (36 h; E) and
cysts (C). Note the change of localization from cytoplasm to the nuclei during the
differentiation process. Nuclei were stained with DAPI (blue). DIC (differential inter-
ference contrast) microscopy is shown. B) IFA and confocal microscopy on ADIK101A-HA
transgenic cells labeled with Texas Red-conjugated anti-HA mAb (red) and anti-
citrulline pAb (green). Note absence of citrullination in the nuclei of ADIK101A-HA trans-
genic cells. Nuclei were stained with DAPI (blue). DIC (differential interference contrast)
microscopy is shown.
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3.1. Lysine residue 101 of ADI is the SUMOylation site
Some previous and independent experiments suggest that the
SUMOylated form of ADI translocates to the nuclei during encystation.By Western blot and immunoprecipitation assays, we previously dem-
onstrated that the 85 kDa band corresponded to the SUMOylated form
of ADI and was also present in the nuclear fraction of encysting tro-
phozoites [5]. Moreover, we found that ADI cytoplasmic-to-nuclear
relocalization occurred at the end of the cyst differentiation, when the
encysting cells are full of ESVs [5].
These previous results prompted us to analyze the time-lapse of ADI
and SUMO protein colocalization in the nuclei during encystation. For
this, trophozoites overexpressing ADI (ADI-HA) were induced to encyst
and tested using both anti-HA and a speciﬁc mAb raised against giardial
SUMO [14]. Increased localization of ADI-HA and SUMOwas observed in
the nuclei during the encystation process, showing a peak between 24
and 36 h after induction of the encystation process but decreasing
after that time (Fig. 1A). Quantitative colocalization analysis demon-
strated partial colocalization between ADI-HA and SUMO (Fig. 1A,
scatter plots). The scatter plots estimate the amount of ﬂuorescence de-
tected, based on localization of SUMO (red, y-axis) and ADI-HA (green,
x-axis). Colocalized pixels (yellow) are located along the diagonal of the
scatter gram. This partial colocalization was supported by the results of
the Mander's (M) overlap coefﬁcient, which was high at all times. The
partial colocalization of both proteins is not surprising, taking into
account that not all the ADI protein is SUMOylated and that there are
many other proteins that might be modiﬁed by SUMO.
In order to conﬁrm these results, trophozoites overexpressing SUMO
(SUMO-HA) were tested using anti-HA mAb to detect SUMO-HA and a
polyclonal antibody against ADI. Similar to the previous observation,
the localization of ADI changed from the cytoplasm to the nuclear
envelope, ending inside the nuclei as encystation progressed. Also, a
clear co-localization with the SUMO-HA protein was observed with
Mander's overlap coefﬁcient, which varied between 0.8757 and
0.9985. Surprisingly, although SUMO-HA transgenic trophozoites did
not show differences in the production of ESVs (Suppl. Fig. 1A), these
transgenic cells were unable to produce cysts even 72 h post induction.
Moreover, analysis of SUMO-HA encysting cells showed that there is no
expression of CWP1 when SUMO-HA was highly expressed in the
nuclei, co-localizing with ADI (Suppl. Fig. 1B, arrow). On the other
hand, similar towhatwe have previously observed in ADI-HA transgenic
cells, CWP1 is observed in SUMO-HA cells mildly expressing SUMO-HA
(Suppl. Fig. 1B, arrowhead). These results suggest that SUMO is more
available, either because the protein is overexpressed or because the
HA tagging of SUMO disrupts its function and interaction with other
cellular components. Therefore SUMO protein might be regulating the
ADI function because, when SUMO protein is particularly accessible,
ADI might have more chances of being SUMOylated and translocate to
the nuclei early during encystation.
SUMO substrates show SUMOylation sites that follow a consensus
motif with ψ-K-S-E/D (where ψ is a hydrophobic amino acid) [30–33].
We previously predicted two motifs with high probability as
SUMOylation sites of ADI by using SUMOplot™ [5]. However, a number
of more reliable programs for predicting SUMOylation sites are now
available (e.g. SUMOsp 2.0 or PCI-SUMO), recognizing only the lysine
101 (K101) to be SUMOylated, with a prediction sensitivity of 89.12%.
Analysis of the secondary structure using Phyre2 showed that this
residue is located in a loop ﬂanked by two helixes and the lysine is
clearly exposed, as in most of the known SUMO target sites that fall
either in unstructured N or C termini or in a loop region (Fig. 2A) [34,
35].
To experimentally examine if the K101 residue is the SUMOylated
residue in ADI, a mutant lacking the putative SUMOylation site was
generated fromADI. Beforemaking themutation of theK101 for alanine
(A), and in order to predict if the mutation would affect ADI function,
the SNAP method (developed by Yana Bromberg at Columbia Universi-
ty) was used. We found that the K101 mutation is “neutral” predicting
that the resulting point-mutated protein is not functionally discernible
from the native ADI. Therefore, the residue K101 was individually
replaced by alanine (A) in the context of an expression vector encoding
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(ADIK101A-HA). When we used anti-HA mAb or an anti-ADI polyclonal
antibody, we observed that the mutation did not change the cytoplas-
mic and ﬂagellar localization (arrow) of the enzyme in growing (T)
and encysting (E) ADIK101A-HA transgenic trophozoites (Fig. 2B). Also,
a minor portion of ADIK101A-HA was found in the nuclei in these
encysting cells (see below). Quantitative colocalization analysis demon-
strated a high degree of colocalization between ADI and ADIK101A-HA
(scatter plots on the right). The scatter plots indicate a yellow
monopartite diagonal scatter pattern, which veriﬁes the colocalization
of both proteins, which is also supported by the results of the Mander's
(M) overlap coefﬁcient, which were 0.9985 and 0.9744, respectively.
Conversely to cells overexpressing ADI-HA, anti-HAmAb did not detect
the SUMOylated 85 kDa band in ADIK101A-HA encysting cells byWestern
blotting (Fig. 2C). Also, we observed that therewas amild enrichment of
the bands of lowmolecular weight in encysting ADIK101A-HA cells. These
results suggest that, in these cells, ADIK101A-HA was not SUMOylated
and thus never expressed as an 85 kDa band. Another possibility
is that the lower bands may correspond to degradation products of
SUMOylated forms of the enzyme. To elucidate this, we performed
immunoprecipitation assays using anti-SUMO mAb (13C5) in either
ADI-HA or ADIK101A-HA encysting cells (Fig. 2D). We found that anti-
SUMO was able to immunoprecipitate the 85 kDa band of ADI-HA,
conﬁrming our previous results using a commercial antibody against
SUMO1 [5]. However, neither the 85 kDa band nor bands of lower
molecular weight were immunoprecipitated from ADIK101A-HA cells,
discarding the possibility that SUMOylated forms of ADI had been
degraded. Taking into account that SUMO modiﬁcation is related to
protection of the proteins from degradation, it is possible that in this
case, the absence of SUMOylation of ADI favors its partial degradation.
To test the PAD activity of ADIK101A-HA, active ADIK101A-HA enzyme
was puriﬁed from transgenic trophozoites using anti-HA antibody and,
after incubation with the His6-CRGKA peptide, was analyzed using
anti-citrulline (modiﬁed) detection kit. After His6-CRGKA puriﬁcation
and Dot blotting, we found that ADIK101A-HA, but not a non-related
enzyme (ESCP), citrullinates the His6-CRGKA peptide (Fig. 2E). ADI-HA
puriﬁed enzyme was used as a positive control.
3.2. Nucleocytoplasmic shuttling of ADI partially depends on SUMOylation
When the ADIK101A-HA transgenic trophozoites were induced to
encyst and analyzed by IFA and confocal ﬂuorescent microscopy 36 h
after induction, a drastic reduction of ADIK101A-HA nuclear localiza-
tion was observed compared with ADI-HA trophozoites (Fig. 3A
and B) or wild-type trophozoites (not shown). This suggests that
the SUMOylation of the enzyme promotes its translocation to the
nuclei.
Using the anti-SUMO (13C5) mAb and the anti-HA mAb to detect
ADIK101A-HA in IFA and confocal microscopy, no colocalization of
these two proteins in ADIK101A-HA transgenic encysting trophozoites
was observed, indicating the lack of SUMOylation of ADIK101A-HA
(Fig. 3C). This was conﬁrmed by the quantitative colocalization analysis
showing a Mander's coefﬁcient b 0.500 (Fig. 3C, right panels). Interest-
ingly, even though a small number of cells showed ADIK101A-HA in the
nuclei at 36 h post induction, there was no colocalization of this protein
with SUMO (Fig. 3C, 36 h). Because the presence of ADI in the nuclei was
dramatically reduced in ADIK101A-HA transgenic encysting trophozoites,
it became clear that nuclear translocation of ADI depends strongly, but
not exclusively, on SUMOylation.
To track whether nuclear translocation of ADIK101A-HA occurs
synchronically with the encystation, as was previously observed for
ADI-HA and native ADI [5], a time-dependent analysis was performed
in ADIK101A-HA cells. Detailed analysis of the localization of ADIK101A-
HA, together with the appearance of the CWP1, showed a progressive
translocation of ADIK101A-HA toward nuclei during encystation in
few cells, particularly when the encysting trophozoites were full ofESVs (Fig. 3D, 32–40 h). Nevertheless, the non-SUMOylated ADI
(ADIK101A-HA) appeared in the nuclei of ADIK101A-HA cells later during
encystationwhen it was comparedwith the nuclear presence of ADI-HA
in ADI-HA transgenic cells (Fig. 1A, 24 h). On the other hand, in the
forming cyst, the localization of ADIK101A-HA in the nuclei decreased
and no nuclear localization in the mature cyst was found (Fig. 3D, 48–
56 h). All together, these results indicate that there is a shuttle of ADI be-
tween cytoplasm and nuclei during the encystation with SUMOylation
improving the efﬁciency of nuclear localization. However, we cannot
decipher if the impaired localization of ADIK101A-HA in the nuclei is
because of a lower efﬁciency in nuclear import or if it is related to a
failure in retention of the enzyme inside the nuclei. Moreover, although
the SUMOylation of the ADI clearly promotes its movement to the
nuclei, there may be other signals involved in the process.3.3. Nuclear localization signals are critical for nuclear entry of ADI
Proteins destined for transport to the nucleuswith amolecularmass
higher than 50 kDa contain amino acid-targeting sequences called nu-
clear localization signals (NLSs). In order to ﬁnd potential NLS
sequences within ADI, bioinformatic analysis was performed using the
PSORT II program (http://psort.nibb.ac.jp/form2.html). The results
showed two putative NLSs in the ADI sequence: a conserved bipartite
NLS, RRGIVMGQFQAPQRRREQ, which shows two basic residues (RR),
11 spacer residues and another basic region consisting of 3 basic
residues (RRR), and a monopartite consensus sequence starting with
proline and followed within 3 residues by a basic segment containing
three arginine residues (PQRRREQ). Given that the bipartite consensus
sequence consists of the monopartite consensus sequence plus a
linker and upstream basic residues, all proteins containing a putative
bipartite sequence also, by deﬁnition, contain a monopartite consensus
sequence.
In an attempt to reveal whether the conserved NLSs in ADI are
functional and are responsible for the entry of ADI into the nuclei,
some mutations were constructed and their cellular localization
was followed in transfected cells during encystations. Based on
bioinformatic analysis, the amino acid mutations were designed tak-
ing into account their inﬂuence in the theoretical localization of the
protein after the substitution for alanine (Table 1). To analyze if the
mutation affects protein stability, cell lysates from mNLS1–mNLS3
transgenic cells were analyzed by immunoblotting. Our results
showed that the constructs showed the same pattern of protein
bands, including the 85 kDa band corresponding to the SUMOylated
form of ADI (Fig. 4A). To explore the PAD activity of the mutant con-
structs, a citrullination assay was performed using puriﬁed enzyme
from the constructs and the His6-CRGKA peptide. ADI-HA puriﬁed
enzyme was used as a positive control. We found that all the con-
structs showed PAD activity (Fig. 4B).
All the substitutions made led to a diminished accumulation of
ADI in the nuclei in encysting cells (after 36 h) compared with ADI-
HA transgenic cells (Figs. 4C, D). However, substitution of the ﬁrst
two basic residues (R and R: mNSL1) with alanine residues at posi-
tions 181–182 in the ﬁrst part of the conserved bipartite NLS resulted
in a lower decrease compared with the other mutations (60%)
(Fig. 4E). Substitution of valine and methionine (V and M: mNSL2)
for alanine residues and substitution of proline for alanine in the
ﬁrst part of the monopartite NLS (P: mNLS3) showed a decrease of
90 and 85%, respectively, compared with ADI-HA transgenic cells.
The results found in mNLS1 and mNLS3 transgenic cells matched
the in silico prediction; however in mNLS2 the shuttle to the nuclei
would theoretically not be affected. These results suggest that both
the bipartite and the monopartite NLSs are active sites involved in
the entry of ADI to the nuclei and that mutations in other amino
acids, despite basic residues, alter the entry of the protein to the
nuclei.
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tions in the NLS sites described, in order to obtain double mutants to
explore the subcellular localization of ADI. However, none of thetransfection made in Giardia trophozoites produced viable cells, as
occurred with other giardial proteins with expressions that are
toxic for the cells [36].
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Fig. 7.Model of the translocation of ADI to the nuclei during encystation. During the differ-
entiation process conjugation of ADI to the SUMO protein in the cytoplasm (A) seems to
increase the efﬁciency of the translocation of the enzyme. (B) Nuclear localization signals
are also involved. Inside the nuclei, ADI acts as a peptidyl arginine deiminase (C). As a con-
sequence of ADI translocation, there is a downregulation of the expression of CWP1 and
CWP2 proteins and cyst formation.
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Having demonstrated that ADI translocates to the nuclei during the
encystation process, its function as a PADwithin them (36 h after induc-
tion of encystation) was next evaluated. IFA and confocal microscopy
using a modiﬁed anti-citrulline antibody revealed that the labeling
changed during differentiation, from a cytoplasmic localization in
wild-type trophozoites to a nuclear localization in encysting cells
(Fig. 5A), still supporting the function of ADI as a PAD. The chromatin
of both nuclei was labeled, as previously shown for the labeling of acetyl
andmethyl-modiﬁed histones [37,38].Whenwe analyzed citrullination
in ADIK101A-HA transfected cells, we found no citrullination in the nuclei,
showing always a cytoplasmic pattern (Fig. 5B). As the whole, these
results suggest that the translocation of ADI to the nuclei during
encystation is related to its function as a PAD.Fig. 6. ADI downregulates the encystation process.A) Real-time PCR was performed using cwp
induction of encystation. Fold changes inmRNA expression are shownas the ratio of transcript le
to that of gdh. Each sample was loaded in triplicate and experiments were repeated at least t
cytometry assays were performed on non-permeabilized encysting wild-type trophozoites (W
histograms show the result of an unrelated antibody (gray). Percentage of positive cells (cysts)
cells 36 h after induction of the encystation process. The assaywas performedusing primers spe
mRNA expression are shown as the ratio of transcript levels inmNLS transgenic cells relative to
statistically evaluated using Student's t test, *pb 0.05. D) Flow cytometry assays performed inno
mAb (x axis). Overlay histograms show the result of an unrelated antibody (gray). Percentage3.5. ADI regulates the production of mature cysts
As citrullination is known to modulate gene transcription, we per-
formed qRT-PCR of cwp genes using mRNA extracted from wild-type,
ADI-HA and ADIK101A-HA transgenic trophozoites at 36 h of encystation.
ThemRNA levels of the endogenous cwp1 and cwp2 genes in theADI-HA
transgenic cells decreased (p b 0.05) relative to wild-type trophozoites
(Fig. 6A). No signiﬁcant changeswere observed in cwp3 gene. To further
understand the function of giardial ADI, we observed the effect of over-
expression of ADIK101A-HA transgenic cells. We found that the levels of
cwp1, cwp2 and cwp3 increased signiﬁcantly compared with that of
wild-type trophozoites during encystation. These results suggest a role
of ADI in CWPs downregulation during the encystation process. In
order to quantify the cysts within the total population of encysting
cells, ﬂow cytometry was performed using a mAb against CWP1 in
non-permeabilized wild-type as well as in ADI transgenic trophozoites
(Fig. 6B). The cells were not permeabilized in order to consider just
the mature or forming cysts, which express CWP1 on the surface. As a
control, a non-related antibody was used (gray line). The percentage
of forming cysts was found to markedly decrease in ADI-HA transfected
cells compared to wild-type. On the other hand, when cyst production
was tested in ADIK101A-HA transfected trophozoites, cyst production
signiﬁcantly increased compared to ADI-HA transfected trophozoites.
This data provides evidence that suggest that SUMOylation and ADI
translocation to the nuclei are probably related to the downregulation
of proteins involved in the encystation process in G. lamblia.
To analyze if the impaired localization ofmNLS transgenic cells in the
nuclei is related to cwp gene expression, we performed qRT-PCR using
mRNA from mNLS transgenic cells during encystation (Fig. 6C). We
found that cwp1 and cwp3 gene expression showed and increased
(mNLS2 and mNLS3) or there were no differences (mNLS1) related to
wild-type trophozoites. By contrast, cwp2 gene expression showed a
signiﬁcant decrease (mNLS1 and mNLS2) or no differences in mNLS3.
When we analyzed the percentage of cyst produced by ﬂow cytometry
assays, we found that in all mutant transgenic cells, there were inter-
mediate percentages of cysts between ADI-HA and ADIK101A-HA
encysting cells. It is important to note that in these mNLS transgenic
trophozoites, SUMOylation of the enzyme takes place; therefore the
enzyme that gets into the nuclei is still functional, explaining the partial
downregulation of cwp genes in these mutant cells.
4. Discussion
G. lamblia encystation is a highly interesting biological process
in which trophozoites perceive adverse conditions and unleash an
organized process in which synthesis, accumulation and secretion of
cyst wall components are critical steps. Despite considerable informa-
tion at the cellular level, the basis of molecular mechanisms involved
in the generation, regulation and downregulation of gene expression
during encystation remains unclear. This study shows evidence related
to the downregulation of cwps genes, in a process closely related to
ADI translocation to the nuclei during encystation. Two types of
protein posttranslational modiﬁcations were involved. One was the
SUMOylation of ADI, which contributes to improve the efﬁciency of
nuclear import or permanence of the enzyme inside the nuclei, and1-3 gene-speciﬁc primers in wild-type, ADI-HA and ADIK101A-HA transgenic cells, 36 h after
vels inmNLS transgenic cells relative towild-type trophozoites. Expressionwasnormalized
hree times. The data was statistically evaluated using Student's t test, *p b 0.05. B) Flow
t), ADI-HA or ADIK101A-HA transgenic trophozoites using anti-CWP1 mAb (x axis). Overlay
is indicated. C) Quantitative real time PCR analysis of gene expression inmNLS transgenic
ciﬁc for cwp1-3 genes. Transcript levelswere normalized to gdh RNA levels. Fold changes in
wild-type (Wt) trophozoites. Experiments were repeated at least three times, and data was
n-permeabilizedmNLS transgenic cells 36 h after induction of encystation using anti CWP1
of positive cells (cysts) is indicated.
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function of ADI as a PAD in the nuclei. These results provide insights
into possible pathways bywhich ADI participates during stage differen-
tiation in this protozoan parasite.
Since the discovery of the protein modiﬁer SUMO about 16 years
ago, much has been learned about the enzymatic system mediating
SUMO conjugation and deconjugation in eukaryotic cells. Also, the
number of proteins identiﬁed as substrates of SUMO modiﬁcation is
rapidly increasing. However, much remains to be understood about
how SUMOylation modiﬁes the functions of these proteins [39]. While
many questions remain unresolved in more evolved cells, the situation
is evenmore unclear in parasites. The SUMOconjugation systemhas been
described in Toxoplasma gondii, Plasmodium falciparum, Trypanosoma
cruzi, Schistosomamansoni and G. lamblia [14,40–43]. Many of these stud-
ies are just descriptive of the enzymes involved in the SUMO cycle and, in
only a few cases, the SUMO substrates have been established. Still, the bi-
ological role of SUMO conjugation in parasites remains to be elucidated.
Recently, it has been demonstrated that paraﬂagellar rod protein
(PFR1) is a ﬂagellar substrate of SUMO in T. cruzi and may play a role
in differentiation of T. cruzi [44]. Our studies also showed that the en-
zyme ADI is a SUMOylated enzyme in G. lamblia [5], and that ADI is spe-
ciﬁcally SUMOylated on Lys101, inside a typical SUMOylationmotif that
is not part of a helix according to the secondary structure prediction. The
described enzymes of the SUMOylation pathway are both in the cyto-
plasm and surrounding the nuclei [14], and so SUMOylation of ADI
may take place either in the cytoplasm or in the perinuclear region.
Our results indicate that SUMOylation of ADI improved nuclear import
efﬁciency during encystation, as was suggested to be one of the func-
tions of SUMOconjugation in other cells [45–47]. However, in eukaryot-
ic cells, the best understood pathway of nuclear-cytoplasmic transport
is a classic nuclear import pathway, where proteins that crisscross the
nuclear membrane contain a stretch of basic amino acid sequence: the
NLSs. ADI shows both a monopartite and a bipartite putative NLSs, and
they were found to be involved in the translocation of the enzyme to
the nuclei. Proteins with NLSs are transported across the nuclear enve-
lope by a family of transport proteins called karyopherins or importins.
In the Giardia genome data base, only the importin β-3 subunit
(GL50803_15106) is described. It shows the HEAT domain involved in
intracellular transport and contains a domain with high probability of
SUMO interaction. The involvement of this importin in ADI transport
across the nuclear membrane is a matter of ongoing experiment. Inter-
estingly, it is known that nuclear-cytoplasmic transport modulated
by posttranslational modiﬁcation of the cargo protein, including
SUMOylation, could mask or expose the NLS of the protein. We found
that ADI shuttle to the nuclei even in the absence of SUMOylation of
the enzyme, but the localization of the enzyme in the nuclei is higher
when ADI is SUMOylated. These results may be explained taking into
account the molecular consequences of SUMOylation. One possible
explanation is that SUMOylation keeps the enzyme inside the nuclei,
as was demonstrated in other cells [48]. Another possibility is that the
SUMOylation of ADI may lead to a conformational change in ADI,
which now exposes the NLS or the site where it is bonded to importin
β. It will be interesting to further explore if there is an association of
the SUMOylated form of ADI with importins, or with other cargo pro-
teins, in order to crisscross the nuclear membrane.
We have previously demonstrated that the enzyme ADI, besides its
role as a metabolic enzyme, acts as a PAD during the antigenic variation
process [5]. Here, using an antibody against modiﬁed citrulline, we
found that the enzyme was able to deiminate arginine residues within
nuclear proteins during encystation. However, using this detection
method, it is possible to determine the citrullination state of an entire
protein without being able to identify the protein or annotate the
location of the converted arginine. In eukaryotic cells, PAD4 has been
described as being recruited to the promoters of numerous genes
producing the deimination (citrullination) of the histones H3 and
H4, with this modiﬁcation being associated with the decreasedtranscription level of those genes via an unknown mechanism [49].
This suggested that the ADI enzymemight be able to deiminate histones
during the encystation of G. lamblia. In preliminary studies, we puriﬁed
nuclear proteins fromgrowing and encysting cells and afterMALDI-ToF-
MS analysis we identiﬁed histone H4, histone H2A and histone H2B.
Using the anti-citrulline (modiﬁed) antibody and Western blotting
assay, we found citrullinated proteins identiﬁable in the 11–16 kDa re-
gion, matching the predicted masses of histone proteins in encysting
cells. Although this result suggests histone citrullination, complementa-
ry experiments are needed to conﬁrm the presence of citrullinated his-
tones during encystation. In Giardia, very little is known about
epigenetic modiﬁcations of histones. Lysine methylation has been sug-
gested in histone H3, but arginine methylation has not been studied
yet. Unraveling the importance of posttranslational modiﬁcation of nu-
clear proteins will undoubtedly bring forth new knowledge to the ﬁeld
of epigenetic regulation of gene expression in Giardia.
Given that the relocalization of ADI from the cytoplasm to the nucle-
us depends on the differentiation of the parasite, it is possible that a
cascade of events is involved in this mechanism. Although it has been
observed that the lack of cholesterol triggers the encystation process,
it is not known how cholesterol deprivation initiates speciﬁc gene
regulation. In the upregulation of encystation gene expression, several
transcriptional factors have been identiﬁed, such as Myb-2 [50,51],
GARP [52], WRKY [53], E2F [54], AT-rich interaction domain (ARID)
[55], and recently Pax proteins (1 and 2) [56]. All these transcription
factors are involved in the upregulation of cwp genes and therefore
involved in cwp gene regulation during encystation. However, as the
encystation process progresses, there may also be signals to down-
regulate cwp expression. We suggest that the enzyme ADI is involved
in this process, because in ADI mutants in which SUMOylation is
absent (ADIK101A-HA trophozoites) and translocation to the nuclei is
diminished, the quantity of cysts produced is higher than in ADI-HA
transfected cells. We therefore may draw a model in which there
would be a coordinated cascade of events (Fig. 7). The ﬁrst signal that
drives ADI to the nuclei would be the SUMOylation of the enzyme
which probably exposes NLS signals promoting the entry of the enzyme
to the nuclei. Once inside the nuclei, ADI acts as a PAD and, by an
unknown mechanism, induces the downregulation of cwp genes,
allowing the encystation process to end. Our results therefore establish
an important integration point for two protein-modifying pathways in
Giardia, inwhich SUMOylation and deimination converge as key players
in the regulation of cyst production in this parasite.
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